1. Home
  2. WVE vs GES Comparison

WVE vs GES Comparison

Compare WVE & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • GES
  • Stock Information
  • Founded
  • WVE 2012
  • GES 1981
  • Country
  • WVE Singapore
  • GES Switzerland
  • Employees
  • WVE N/A
  • GES N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • GES Apparel
  • Sector
  • WVE Health Care
  • GES Consumer Discretionary
  • Exchange
  • WVE Nasdaq
  • GES Nasdaq
  • Market Cap
  • WVE 915.6M
  • GES 872.4M
  • IPO Year
  • WVE 2015
  • GES 1996
  • Fundamental
  • Price
  • WVE $8.31
  • GES $16.98
  • Analyst Decision
  • WVE Strong Buy
  • GES Buy
  • Analyst Count
  • WVE 14
  • GES 5
  • Target Price
  • WVE $20.79
  • GES $19.25
  • AVG Volume (30 Days)
  • WVE 3.6M
  • GES 572.9K
  • Earning Date
  • WVE 11-07-2025
  • GES 11-25-2025
  • Dividend Yield
  • WVE N/A
  • GES 5.30%
  • EPS Growth
  • WVE N/A
  • GES N/A
  • EPS
  • WVE N/A
  • GES 0.35
  • Revenue
  • WVE $93,946,000.00
  • GES $3,091,508,000.00
  • Revenue This Year
  • WVE N/A
  • GES $7.97
  • Revenue Next Year
  • WVE $6.26
  • GES $3.46
  • P/E Ratio
  • WVE N/A
  • GES $48.96
  • Revenue Growth
  • WVE N/A
  • GES 7.84
  • 52 Week Low
  • WVE $5.28
  • GES $8.48
  • 52 Week High
  • WVE $16.74
  • GES $18.07
  • Technical
  • Relative Strength Index (RSI)
  • WVE 56.37
  • GES 65.47
  • Support Level
  • WVE $8.18
  • GES $16.75
  • Resistance Level
  • WVE $9.75
  • GES $17.04
  • Average True Range (ATR)
  • WVE 0.64
  • GES 0.08
  • MACD
  • WVE 0.14
  • GES -0.03
  • Stochastic Oscillator
  • WVE 48.94
  • GES 80.00

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About GES Guess? Inc.

Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.

Share on Social Networks: